Zhejiang Nhu Co Ltd

002001

Company Profile

  • Business description

    Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives, and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer, and Anti-bacterial, with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3, and coenzyme Q10, and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.

  • Contact

    No.418 Xinchang Dadao West Road
    Xinchang County, Qixing Sub-district
    Zhejiang Province
    Shaoxing312500
    CHN

    T: +86 57586127777

    https://www.cnhu.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    11,369

Stocks News & Analysis

stocks

Procter & Gamble earnings: Frigid sales and margins don’t suggest cracks in its standing

North America was a notable blemish, down 2% on an organic basis.
stocks

Our view on Santos after production is ramped up

Barossa at 75% capacity and Pikka undergoing commissioning.
stocks

GE Aerospace earnings: No good deed goes unpunished

We’ve raised our fair value estimate of GE Aerospace stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,189.9015.700.17%
CAC 408,132.8516.04-0.20%
DAX 4024,893.4536.980.15%
Dow JONES (US)49,108.47275.54-0.56%
FTSE 10010,141.049.01-0.09%
HKSE26,749.51119.550.45%
NASDAQ23,537.41101.390.43%
Nikkei 22553,846.87157.980.29%
NZX 50 Index13,448.24108.63-0.80%
S&P 5006,919.275.920.09%
S&P/ASX 2008,860.1015.000.17%
SSE Composite Index4,136.1613.590.33%

Market Movers